Ozoir-la-Ferriere, France

Clemence Rauch-Desanti

This inventor holds 1 USPTO granted patent. Top assignees: Jagotec Ab, Synthelabo. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clemence Rauch-Desanti. Retrieved from https://idiyas.com/inventor/clemence-rauch-desanti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 98(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Clemence Rauch-Desanti: Innovator in Pharmaceutical Technology

Introduction

Clemence Rauch-Desanti is a notable inventor based in Ozoire la Ferriere, France. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of drug delivery systems.

Latest Patents

Clemence holds a patent for a "Tablet with controlled release of alfuzosine chlorhydrate." This innovation showcases her expertise in creating formulations that enhance the efficacy of medications.

Career Highlights

Throughout her career, Clemence has worked with prominent companies such as Synthelabo and Jagotec AB. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking advancements in the pharmaceutical industry.

Collaborations

Clemence has collaborated with talented individuals, including Lauretta Maggi and Ubaldo Conte. These partnerships have fostered a creative environment that has led to innovative solutions in drug development.

Conclusion

Clemence Rauch-Desanti's work exemplifies the impact of innovation in pharmaceuticals. Her contributions continue to influence the industry and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…